Skip to search formSkip to main contentSkip to account menu

camostate-mesilate

Known as: CAMOSTAT MESYLATE, camostat mesilate, Camostat Monomethanesulfonate 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
It is well known that the intestinal stability and absorption of protein drugs are improved when enzyme inhibitors/permeation… 
2010
2010
BackgroundThe aim of the present study was to examine the potential efficacy of camostat mesilate, a protease inhibitor, against… 
2007
2007
We hypothesized that endogenous CCK reduces food intake by activating the dorsal vagal complex (DVC) and the myenteric neurons of… 
2006
2006
BackgroundReflux of the duodenal contents with gastric acid has been reported to contribute to the development of esophageal… 
Highly Cited
2001
Highly Cited
2001
The objective of this study was to estimate colon-specific delivery of insulin and (Asu(1,7))eel-calcitonin using novel… 
1999
1999
OBJECTIVE To characterise alkaline reflux oesophagitis after total gastrectomy in rats from the standpoints of cell proliferation… 
1994
1994
1. The metabolic fate of N,N-dimethylcarbamoylmethyl 4-(4-guanidino[14C]benzoyloxy)phenylacetate methanesulphonate (14C-camostat… 
1992
1992
Abstract— The effects of proteolytic enzyme inhibitors, aprotinin, soybean trypsin inhibitor and camostat mesilate as absorption… 
1989